Pharming Group N.V. (PHGUF)
OTCMKTS
· Delayed Price · Currency is USD
0.9130
+0.0198 (2.22%)
At close: Apr 29, 2025
Pharming Group Revenue
Pharming Group had revenue of $79.09M in the quarter ending March 31, 2025, with 42.29% growth. This brings the company's revenue in the last twelve months to $320.71M, up 24.13% year-over-year. In the year 2024, Pharming Group had annual revenue of $297.20M with 21.15% growth.
Revenue (ttm)
320.71M
Revenue Growth
+24.13%
P/S Ratio
1.98
Revenue / Employee
793.83K
Employees
404
Market Cap
635.73M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 297.20M | 51.88M | 21.15% |
Dec 31, 2023 | 245.32M | 39.69M | 19.30% |
Dec 31, 2022 | 205.62M | 6.75M | 3.39% |
Dec 31, 2021 | 198.87M | -13.30M | -6.27% |
Dec 31, 2020 | 212.17M | 22.79M | 12.03% |
Jan 1, 2020 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Pharming Group News
- 7 days ago - Pharming Group N.V. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 7 days ago - Pharming Group N.V. (PHAR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Pharming Group N.V. GAAP EPS of $0.02, revenue of $79.1M misses by $1.82M - Seeking Alpha
- 8 days ago - Earnings Scheduled For May 8, 2025 - Benzinga
- 8 days ago - Pharming Group reports first quarter 2025 financial results and provides business update - GlobeNewsWire
- 15 days ago - Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director - GlobeNewsWire
- 22 days ago - Pharming Group to report first quarter 2025 financial results on May 8 - GlobeNewsWire
- 23 days ago - Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS - GlobeNewsWire